Daratumumab With Extended Maintenance for Pediatric Proliferative Glomerulonephritis With Monoclonal Immunoglobulin Deposits: A Case Report
Pediatric Blood & Cancer · 20.11.2026
DOI: 10.1002/1545-5017.70845 ↗Kurz gefasst
Leserbrief in der Zeitschrift Pediatric Blood & Cancer, online erschienen am 20.11.2026. Verfasst von Joshua Glass und 4 weiteren Autor:innen. Beteiligte Einrichtung: Children's Cancer Institute, Joseph M. Sanzari Children's Hospital, Hackensack University Medical Center, Hackensack, New Jersey, USA. Die Arbeit nennt 29 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Children's Cancer Institute, Joseph M. Sanzari Children's Hospital, Hackensack University Medical Center, Hackensack, New Jersey, USA.
- Division of Pediatric Nephrology, Department of Pediatrics, Joseph M. Sanzari Children's Hospital, Hackensack University Medical Center, Hackensack, New Jersey, USA.
- Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, New York, USA.
ORCID-Profile: Joshua Glass, Burton Appel
Zitieren
APA
Glass, J., Jain, N. G., Kudose, S., Carlo, A., & Appel, B. (2026). Daratumumab With Extended Maintenance for Pediatric Proliferative Glomerulonephritis With Monoclonal Immunoglobulin Deposits: A Case Report. Pediatric Blood & Cancer. https://doi.org/10.1002/1545-5017.70845
Vancouver
Glass J, Jain NG, Kudose S, Carlo A, Appel B. Daratumumab With Extended Maintenance for Pediatric Proliferative Glomerulonephritis With Monoclonal Immunoglobulin Deposits: A Case Report. Pediatric Blood & Cancer. 2026. doi:10.1002/1545-5017.70845
BibTeX
@article{Glass2026,
author = {Glass, Joshua and Jain, Namrata G and Kudose, Satoru and Carlo, Ashley and Appel, Burton},
title = {Daratumumab With Extended Maintenance for Pediatric Proliferative Glomerulonephritis With Monoclonal Immunoglobulin Deposits: A Case Report},
journal = {Pediatric Blood & Cancer},
year = {2026},
doi = {10.1002/1545-5017.70845}
}
EUVIMED